Icotrokinra vs Thymalin
Overview
Icotrokinra and Thymalin are both immune support peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Icotrokinra and Thymalin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | Thymalin | |
|---|---|---|
| Category | Immune Support | Immune Support |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | — | 10 mg |
| Frequency | — | daily for 10-day cycles |
| Reported benefits | — | Thymus rejuvenation, immune enhancement, anti-aging immune support |
| Reported side effects | — | Well-tolerated during cycles |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while Thymalin falls under Immune Support. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Icotrokinra: FDA-approved. Thymalin: not FDA-approved; treated as a research compound.
Dosing. Typical dosing for Icotrokinra is not catalogued. Thymalin is typically dosed at 10 mg (daily for 10-day cycles).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and Thymalin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and Thymalin?
- Icotrokinra and Thymalin are both immune support peptides, but they differ in mechanism, dosing, and regulatory status. Icotrokinra is FDA-approved for one or more indications, whereas Thymalin is not FDA-approved; generally classified as a research compound.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is Thymalin used for?
- Thymus restoration peptide.
- Can you take Icotrokinra and Thymalin together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and Thymalin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or Thymalin FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. Thymalin is not FDA-approved; generally classified as a research compound.
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- Thymalin — full monograph: mechanism, research, dosing & references